Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Proactively manage your pharmacy inventory
Anticipate generic drug launch
Manage your formulary budget
Drug patents …
… from Kazakhstan to Kalamazoo
Find generic entry opportunities
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Methods and formulations of cremophor-free taxanes|
|Abstract:||In accordance with the present invention, there are provided composition and methods useful for the in vivo delivery of a pharmaceutically active agent, wherein the agent is associated with a polymeric biocompatible material.|
|Inventor(s):||Desai; Neil P. (Los Angeles, CA), Soon-Shiong; Patrick (Los Angeles, CA)|
|Assignee:||American BioScience, Inc. (Santa Monica, CA)|
Patent Claim Types:|
see list of patent claims
|Use; Formulation; Delivery; Dosage form; Device;|
Back Citations: 11th percentile
Forward Citations: 12th percentile
|Patent Number||Expiration Date|
|6,506,405||January 14, 2015|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Austria||264671||<disabled in preview>|
|Austria||427739||<disabled in preview>|
|Australia||2002303626||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.